NCT05575960 Interpersonal Psychotherapy for Adolescents and Young Adults
| NCT ID | NCT05575960 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linnaeus University |
| Condition | Major Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-10-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-10-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the project is to study the effectiveness of Interpersonal Psychotherapy (IPT) for adolescents with depression. Specific aims are to analyze the effects, change mechanisms, predictors, and implementation of IPT for youth. In this four-year project we will include 60 patients with depression. Outcome will be studied using a quasi-experimental multiple-baseline design. Change mechanisms will be studied in the form of mentalizing, emotion regulation, social support, and working alliance session-by-session, and with post-treatment qualitative interviews about the participants' experiences of change. Predictors of effectiveness of IPT for adolescents will be explored by measuring severity of symptoms, anxiety symptoms, presence and severity of parent-child conflicts, quality of interpersonal relationships, experiences of bullying, and school functioning. The implementation process of IPT for youth will be studied through interviews with adolescents, parents, therapists, co-workers, and local managers. The study is conducted within child and adolescent psychiatric services in Norrköping using a practice-oriented research strategy which emphasizes close collaboration with clinicians. The project is a collaboration between researchers at Linnaeus University and Linköping University, and clinicians at BUP Norrköping.
Eligibility Criteria
Inclusion Criteria: * Major depressive disorder according to the DSM-V * Age 15 to 17,5 years. * Good-enough knowledge in Swedish to be able to read instructions in questionnaires and who do not require an interpreter. Exclusion Criteria: * Ongoing psychosis * Drug or alcohol addiction * Bipolar disorder * Suspected mental retardation * Acute suicidality or severe depression requiring hospitalization * Patients who have started antidepressant medication within the last six weeks will need to wait until medication effects have stabilized.
Contact & Investigator
Fredrik Falkenström, PhD
PRINCIPAL INVESTIGATOR
Linnaeus University
Frequently Asked Questions
Who can join the NCT05575960 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 18 Years, studying Major Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05575960 currently recruiting?
Yes, NCT05575960 is actively recruiting participants. Contact the research team at fredrik.falkenstrom@lnu.se for enrollment information.
Where is the NCT05575960 trial being conducted?
This trial is being conducted at Norrköping, Sweden.
Who is sponsoring the NCT05575960 clinical trial?
NCT05575960 is sponsored by Linnaeus University. The principal investigator is Fredrik Falkenström, PhD at Linnaeus University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.